340 related articles for article (PubMed ID: 11827921)
21. Altered phosphorylated signal transducer and activator of transcription profile of CD4+CD161+ T cells in asthma: modulation by allergic status and oral corticosteroids.
Gernez Y; Tirouvanziam R; Nguyen KD; Herzenberg LA; Krensky AM; Nadeau KC
J Allergy Clin Immunol; 2007 Dec; 120(6):1441-8. PubMed ID: 17919711
[TBL] [Abstract][Full Text] [Related]
22. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.
Mingari MC; Ponte M; Bertone S; Schiavetti F; Vitale C; Bellomo R; Moretta A; Moretta L
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1172-7. PubMed ID: 9448304
[TBL] [Abstract][Full Text] [Related]
23. Anti-Tumor CC49-zeta CD4 T cells possess both cytolytic and helper functions.
Patel SD; Ge Y; Moskalenko M; McArthur JG
J Immunother; 2000; 23(6):661-8. PubMed ID: 11186154
[TBL] [Abstract][Full Text] [Related]
24. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
[TBL] [Abstract][Full Text] [Related]
25. Antigen-specific directional target cell lysis by perforin-negative T lymphocyte clones.
Takayama H; Shinohara N; Kawasaki A; Someya Y; Hanaoka S; Kojima H; Yagita H; Okumura K; Shinkai Y
Int Immunol; 1991 Nov; 3(11):1149-56. PubMed ID: 1760409
[TBL] [Abstract][Full Text] [Related]
26. Modulation of CD4(+)CD28null T lymphocytes by tumor necrosis factor-alpha blockade in patients with unstable angina.
Rizzello V; Liuzzo G; Brugaletta S; Rebuzzi A; Biasucci LM; Crea F
Circulation; 2006 May; 113(19):2272-7. PubMed ID: 16682617
[TBL] [Abstract][Full Text] [Related]
27. Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL).
Porakishvili N; Roschupkina T; Kalber T; Jewell AP; Patterson K; Yong K; Lydyard PM
Clin Exp Immunol; 2001 Oct; 126(1):29-36. PubMed ID: 11678896
[TBL] [Abstract][Full Text] [Related]
28. Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism.
Williams NS; Engelhard VH
J Immunol; 1996 Jan; 156(1):153-9. PubMed ID: 8598456
[TBL] [Abstract][Full Text] [Related]
29. CD4+ T cells engrafted with a recombinant immunoreceptor efficiently lyse target cells in a MHC antigen- and Fas-independent fashion.
Hombach A; Heuser C; Marquardt T; Wieczarkowiecz A; Groneck V; Pohl C; Abken H
J Immunol; 2001 Jul; 167(2):1090-6. PubMed ID: 11441120
[TBL] [Abstract][Full Text] [Related]
30. Cytotoxic CD4+ T cells use granulysin to kill Cryptococcus neoformans, and activation of this pathway is defective in HIV patients.
Zheng CF; Ma LL; Jones GJ; Gill MJ; Krensky AM; Kubes P; Mody CH
Blood; 2007 Mar; 109(5):2049-57. PubMed ID: 17038537
[TBL] [Abstract][Full Text] [Related]
31. CD161 (NKR-P1A) costimulation of CD1d-dependent activation of human T cells expressing invariant V alpha 24 J alpha Q T cell receptor alpha chains.
Exley M; Porcelli S; Furman M; Garcia J; Balk S
J Exp Med; 1998 Sep; 188(5):867-76. PubMed ID: 9730888
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
Sheu BC; Chiou SH; Lin HH; Chow SN; Huang SC; Ho HN; Hsu SM
Cancer Res; 2005 Apr; 65(7):2921-9. PubMed ID: 15805295
[TBL] [Abstract][Full Text] [Related]
33. Increase in perforin-positive peripheral blood lymphocytes in extrinsic and intrinsic asthma.
Arnold V; Balkow S; Staats R; Matthys H; Luttmann W; Virchow JC
Am J Respir Crit Care Med; 2000 Jan; 161(1):182-6. PubMed ID: 10619818
[TBL] [Abstract][Full Text] [Related]
34. Human purified protein derivative-specific CD4+ T cells use both CD95-dependent and CD95-independent cytolytic mechanisms.
Lewinsohn DM; Bement TT; Xu J; Lynch DH; Grabstein KH; Reed SG; Alderson MR
J Immunol; 1998 Mar; 160(5):2374-9. PubMed ID: 9498779
[TBL] [Abstract][Full Text] [Related]
35. Fas-independent cytotoxicity mediated by human CD4+ CTL directed against herpes simplex virus-infected cells.
Yasukawa M; Ohminami H; Yakushijin Y; Arai J; Hasegawa A; Ishida Y; Fujita S
J Immunol; 1999 May; 162(10):6100-6. PubMed ID: 10229852
[TBL] [Abstract][Full Text] [Related]
36. Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines.
Miskovsky EP; Liu AY; Pavlat W; Viveen R; Stanhope PE; Finzi D; Fox WM; Hruban RH; Podack ER; Siliciano RF
J Immunol; 1994 Sep; 153(6):2787-99. PubMed ID: 7915742
[TBL] [Abstract][Full Text] [Related]
37. Characteristics of expanded CD4+CD28null T cells in patients with chronic hepatitis B.
Wang Y; Bai J; Li F; Wang H; Fu X; Zhao T; Xu W; Zhang J; Ni B; Wu Y
Immunol Invest; 2009; 38(5):434-46. PubMed ID: 19811419
[TBL] [Abstract][Full Text] [Related]
38. Increased frequency of CD4+ cells expressing CD161 in cancer patients.
Iliopoulou EG; Karamouzis MV; Missitzis I; Ardavanis A; Sotiriadou NN; Baxevanis CN; Rigatos G; Papamichail M; Perez SA
Clin Cancer Res; 2006 Dec; 12(23):6901-9. PubMed ID: 17145807
[TBL] [Abstract][Full Text] [Related]
39. Tumor-infiltrating CD4+ T lymphocytes express APO2 ligand (APO2L)/TRAIL upon specific stimulation with autologous lung carcinoma cells: role of IFN-alpha on APO2L/TRAIL expression and -mediated cytotoxicity.
Dorothée G; Vergnon I; Menez J; Echchakir H; Grunenwald D; Kubin M; Chouaib S; Mami-Chouaib F
J Immunol; 2002 Jul; 169(2):809-17. PubMed ID: 12097384
[TBL] [Abstract][Full Text] [Related]
40. CD11b expression identifies CD8+CD28+ T lymphocytes with phenotype and function of both naive/memory and effector cells.
Fiorentini S; Licenziati S; Alessandri G; Castelli F; Caligaris S; Bonafede M; Grassi M; Garrafa E; Balsari A; Turano A; Caruso A
J Immunol; 2001 Jan; 166(2):900-7. PubMed ID: 11145666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
